PL3299384T3 - Skrócone białko vp4 rotawirusa i jego zastosowanie - Google Patents

Skrócone białko vp4 rotawirusa i jego zastosowanie

Info

Publication number
PL3299384T3
PL3299384T3 PL16795912T PL16795912T PL3299384T3 PL 3299384 T3 PL3299384 T3 PL 3299384T3 PL 16795912 T PL16795912 T PL 16795912T PL 16795912 T PL16795912 T PL 16795912T PL 3299384 T3 PL3299384 T3 PL 3299384T3
Authority
PL
Poland
Prior art keywords
protein
application
truncated rotavirus
rotavirus
truncated
Prior art date
Application number
PL16795912T
Other languages
English (en)
Inventor
Shengxiang Ge
Tingdong LI
Lianzhi JIA
Yijian LI
Miaoge XUE
Yuanjun ZENG
Jun Zhang
Ningshao Xia
Huirong Pan
Original Assignee
Xiamen University
Xiamen Innovax Biotech Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiamen University, Xiamen Innovax Biotech Co., Ltd. filed Critical Xiamen University
Publication of PL3299384T3 publication Critical patent/PL3299384T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/15Reoviridae, e.g. calf diarrhea virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/57Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12311Rotavirus, e.g. rotavirus A
    • C12N2720/12322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12311Rotavirus, e.g. rotavirus A
    • C12N2720/12334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12311Rotavirus, e.g. rotavirus A
    • C12N2720/12351Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL16795912T 2015-05-21 2016-05-20 Skrócone białko vp4 rotawirusa i jego zastosowanie PL3299384T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510260020 2015-05-21
EP16795912.1A EP3299384B1 (en) 2015-05-21 2016-05-20 Truncated rotavirus vp4 protein and application thereof
PCT/CN2016/082780 WO2016184425A1 (zh) 2015-05-21 2016-05-20 截短的轮状病毒vp4蛋白及其用途

Publications (1)

Publication Number Publication Date
PL3299384T3 true PL3299384T3 (pl) 2022-01-24

Family

ID=57319471

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16795912T PL3299384T3 (pl) 2015-05-21 2016-05-20 Skrócone białko vp4 rotawirusa i jego zastosowanie

Country Status (13)

Country Link
US (2) US10723767B2 (pl)
EP (2) EP3299384B1 (pl)
JP (1) JP6808650B2 (pl)
CN (2) CN112724207A (pl)
ES (1) ES2898701T3 (pl)
HR (1) HRP20211838T1 (pl)
HU (1) HUE056952T2 (pl)
LT (1) LT3299384T (pl)
PL (1) PL3299384T3 (pl)
PT (1) PT3299384T (pl)
RS (1) RS62664B1 (pl)
SI (1) SI3299384T1 (pl)
WO (1) WO2016184425A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS62664B1 (sr) 2015-05-21 2021-12-31 Univ Xiamen Okrnjen vp4 protein rotavirusa i njegova primena
CN108371715A (zh) * 2018-01-03 2018-08-07 肖小林 一种病毒的靶向性防治药物
EP4087604A4 (en) * 2020-01-08 2023-11-01 Bharat Biotech International Limited COMPOSITIONS OF VIRAL VACCINES AND THEIR PREPARATION METHODS
CN111175502B (zh) * 2020-01-21 2020-10-27 牡丹江医学院 一种轮状病毒Elisa检测方法及其试剂盒
KR20230082653A (ko) * 2020-10-05 2023-06-08 베링거잉겔하임베트메디카게엠베하 로타바이러스에 대한 백신 접종에 유용한 융합 단백질
CN114657192B (zh) * 2022-03-15 2023-08-01 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 一种EBNA1截短mRNA相关疫苗及其制备方法和应用
WO2024102697A1 (en) * 2022-11-08 2024-05-16 Children's Hospital Medical Center Vp4-based trivalent pseudovirus nanoparticle vaccine for rotavirus and methods of using same
CN116953232B (zh) * 2023-06-06 2025-05-13 山东省农业科学院家禽研究所(山东省无特定病原鸡研究中心) 基于兔轮状病毒vp8*蛋白的间接elisa抗体检测试剂盒
CN119119212B (zh) * 2024-09-18 2025-05-16 江苏三仪动物营养科技有限公司 猪轮状病毒vp4截短蛋白及其表达和防治猪腹泻的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8821077D0 (en) * 1988-09-08 1988-10-05 Wellcome Found Peptides
GB9919468D0 (en) * 1999-08-17 1999-10-20 Smithkline Beecham Biolog Vaccine
MY133158A (en) * 1999-08-17 2007-10-31 Smithkline Beecham Biologicals S A Vaccine
CA2513388C (en) * 2003-01-10 2013-06-11 Lorenza Gonzalez-Mariscal Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
CN100448485C (zh) * 2003-09-02 2009-01-07 葛兰素史密丝克莱恩生物有限公司 疫苗
WO2006007555A2 (en) * 2004-07-01 2006-01-19 Children's Medical Center Corporation ¨ Rotavirus antigens
CA3121654A1 (en) 2009-05-12 2010-11-18 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention New human rotavirus strains and vaccines
CN102618506A (zh) 2012-03-22 2012-08-01 中国医学科学院医学生物学研究所 人轮状病毒毒株及其分离,培养与鉴定方法
KR102162118B1 (ko) 2012-05-11 2020-10-07 메디카고 인코포레이티드 식물에서 로타바이러스-유사 입자 생산
CN103304642B (zh) 2013-06-06 2015-01-07 黑龙江八一农垦大学 猪轮状病毒δvp8*亚单位重组蛋白及其应用
CN103319604B (zh) * 2013-06-18 2014-12-10 黑龙江八一农垦大学 一种人轮状病毒△vp8*亚单位重组蛋白及其应用
RS62664B1 (sr) 2015-05-21 2021-12-31 Univ Xiamen Okrnjen vp4 protein rotavirusa i njegova primena

Also Published As

Publication number Publication date
SI3299384T1 (sl) 2022-05-31
US20180141978A1 (en) 2018-05-24
EP3299384B1 (en) 2021-09-08
CN112724207A (zh) 2021-04-30
US11339194B2 (en) 2022-05-24
CN106167518A (zh) 2016-11-30
RS62664B1 (sr) 2021-12-31
LT3299384T (lt) 2021-12-27
EP3299384A1 (en) 2018-03-28
PT3299384T (pt) 2021-11-23
ES2898701T3 (es) 2022-03-08
WO2016184425A1 (zh) 2016-11-24
JP2018520651A (ja) 2018-08-02
HUE056952T2 (hu) 2022-03-28
EP3299384A4 (en) 2018-12-05
EP3981782A1 (en) 2022-04-13
JP6808650B2 (ja) 2021-01-06
US10723767B2 (en) 2020-07-28
US20200308233A1 (en) 2020-10-01
CN106167518B (zh) 2021-01-15
HRP20211838T1 (hr) 2022-03-04

Similar Documents

Publication Publication Date Title
HUS2500022I1 (hu) Terápiás ellenanyagok és alkalmazásaik
IL285375B2 (en) IL-8-binding antibodies and their uses
IL283321A (en) Antibodies against muc16 and their uses
IL258284A (en) Anti-Lag 3 antibodies and their uses
IL257263A (en) Antibodies against angptl8 and their use
IL254955A0 (en) Anti-pacap antibodies and their uses
IL287291A (en) A protein that binds to rgma and its use
PT3299384T (pt) Proteína vp4 de rotavírus truncada e aplicação desta
ZA201900209B (en) Novel natural protein and application thereof
SG11201708624YA (en) Therapeutic antibodies and uses thereof
PL3292154T3 (pl) Przeciwciała przeciwko ludzkiemu HER3 i ich zastosowania
GB201503387D0 (en) Anti-carbapenem antibodies and uses thereof
IL256217A (en) Acceleration tag for the breakdown of protein and its use
SG11201705748SA (en) Anti-glycoprotein antibodies and uses thereof
GB2542851B (en) Container section and container comprising two container sections
GB201707279D0 (en) Multiearphones and polyearphones
GB201513796D0 (en) Materials and Devices